IndraLab

Statements

Naloxone inhibits ITCH. 7 / 7
| 7
reach
"Intracisternal, but not intrathecal, injection of naloxone inhibits cutaneous itch related response in mice."
18981588
reach
"Naloxone and naltrexone also suppress the itch sensation in patients with chronic cholestasis, chronic renal failure and atopic dermatitis (Bergasa et al., 1992; Peer et al., 1996; Metze et al., 1999)[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"
11821035
reach
"As a thirdline option, (3) opioid antagonists (naloxone, nalmefene, naltrexone) have been found to reduce itch severity in patients with PBC [298, [302] [303] [304] ."
19603170
reach
"Interestingly, naloxone, an antidote for morphine, suppresses itch in patients with chronic renal failure and AD 9."
22578170
reach
"As a third-line option, (3) opioid antagonists (naloxone, nalmefene, naltrexone) have been found to reduce itch severity in patients with PBC [XREF_BIBR, XREF_BIBR - XREF_BIBR]."
19603170
reach
"An intradermal injection of serotonin (100 nmol and site) to the rostral back induced scratching, an itch related behavior, which was inhibited by subcutaneous (1 mg/kg) and intracisternal (10 nmol and site) injections of naloxone."
18981588
reach
"As a third-line option, (3) opioid antagonists (naloxone, nalmefene, naltrexone) have been found to reduce itch severity in patients with PBC [298, 302–304]."
19603170